2Moller S,Henriksen J H.Cirrhotic cardiomyopathy[J].Journal of Hepatology,2010,53(11):179-190.
3Enrico M,Antonio A,Domenico M.Cirrhotic cardiomyopathy[J].Journal of the American College of Cardiology,2010,7(56):539-549.
4Palazzuoli A,Gallotta M,Quatrini I,et al.Natriuretic peptides(BNP and NT-pro BNP):measurement and relevance in heart failure.[J]Vascular Health and Risk Management,2010,6(7):411-418.
6Redfield M M,Rodeheffer R J,Jacobsen S J,et al.Plasma brain natriuretic peptide concentration:impact of age and gender JAm[J].Coll Cardiology,2002,40(5):976-982.
7Yildiz R,Yildirim B,Karincaoglu M.Brain natriuretic peptide and severityof disease in non-alcoholic cirrhotic patients[J].Gastroenterol Hepatol,2005,20(12):1115-1120.
8Campell D J,Mitchelhill K I,Schlicht S M.Plasma aminoteniiinal pro-brainnatriuretic peptide:a novel approach to the diagnosis of cardiac dysftmction J[J].Card Failure,2000,6(14):130-139.
9Mc Cullough P A,Omland T,Maisel A S.B-type natriuretic peptides:a diagnosticbreakthrough for clinicians[J].Rev Cardiovasc Med,2003,4(7):72-80.
10Pimenta J,Paulo C,Gomes A,et al.B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis[J].Liver International,2010,30(7):1059-1066.
